Meha Singh - Senior Scientist - AstraZeneca - LinkedIn
WEBView Meha Singh’s profile on LinkedIn, a professional community of 1 billion members.
- Title: Targeted Protein Degradation
- Location: AstraZeneca
- Connections: 151
Meha Singh’s Post - LinkedIn
WEBSVP Early Oncology AstraZeneca 2d Excited to share a paper just published in Science by my friends at Baylor College of Medicine Breast Center that is highly relevant to our RAS ambitions.
EFMC-ISCB 2023 - Programme
WEBNov 16, 2023 · Dr Meha SINGH × Meha joined the Chemical Biology Team at AstraZeneca in August 2020 having worked with MNK-inhibitors for her postdoc at University of Basel, Switzerland.
Meha Singh’s Post - LinkedIn
WEBMeha Singh’s Post. Targeted Protein Degradation. 4mo. Genetics uncovering brain’s role in adult onset obesity. AstraZeneca. 2,969,708 followers. 4mo. A recent publication in Nature Genetics...
Proteomics 2023 | CSHL - Cold Spring Harbor Laboratory
WEBApr 1, 2023 · The overall goal is to train students to identify new opportunities and applications for proteomic approaches in their biological research. 2023 Speakers Include: Angelo Andres, AstraZeneca, Paolo Cifani, Cold Spring Harbor Laboratory. Karl Clauser, Broad Institute of MIT and Harvard.
Accelerating the Validation of Endogenous On-Target ... - ACS …
WEBJul 26, 2022 · In this study, an ultra-performance liquid chromatography-multiple reaction monitoring mass spectrometry platform was utilized to develop a targeted proteomics workflow that can evaluate cellular on-target engagement of covalent molecules in an increased throughput manner.
Our people - AstraZeneca
WEBBe among our employees who continue to make us an innovation-driven company that stands firmly among the world’s leaders in biopharmaceuticals. We have more than 83,000 people across the globe dedicated to push the boundaries of science to …
EFMC-ISCB 2023 - Programme
WEBDr Meha SINGH (ASTRAZENECA, Waltham, United States) 11:50: OC04 - Morphological Profiling of Small Molecules Using the Cell Painting Assay: Dr Slava ZIEGLER (MAX PLANCK INSTITUTE OF MOLECULAR PHYSIOLOGY, Dortmund, Germany) 12:10: Lunch, Networking & Exhibition:
Talking Diaries #12 - Scientific research and career ... - Facebook
WEBTalking Diaries Episode #12 Topic: Scientific research and career opportunities in medicine Speaker: Dr. Meha Singh, Senior Scientist, AstraZeneca...
Discovery, Optimization, and Biological Evaluation of …
WEBJan 16, 2024 · Herein, we describe the discovery and optimization of an arylpyridone series as Cbl-b inhibitors by structure-based drug discovery to afford compound 31. This compound binds to Cbl-b with an IC 50 value of 30 nM and induces IL-2 production in T-cells with an EC 50 value of 230 nM.
Skip to content